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1I thought I should begin this presentation with a bit of background about how 
I’ve come to be thinking about issues around substance use policy.  I did a PhD a 
few years ago now on the sociology of young people’s drinking in Bournemouth, 
focusing on how drinking reflected and constituted gender and class.  Since then 
I’ve been writing mostly about alcohol policy, but I’ve also been working for 
Dorset County Council as part of their Drug and Alcohol Action Team, which 
commissions NHS and third sector providers to deliver treatment for people with 
substance misuse issues.
My presentation today is something of a reflection on the day job using my 
academic social policy perspective.  However, rather than offering some definite 
conclusions about what's happening in relation to substance use policy in local 
authorities, as I'd initially planned, I'm going to identify what I hope could be a 
useful perspective for policy researchers in the field to apply.
You’ve already heard today about the broad brush trends in substance misuse 
policy, and like Virginia Berridge, I think we can trace something of a convergence 
in approaches to substances.  If we consider those substances that we might 
think of as being legal and legitimate, restrictions (or at least concern) have been 
growing in recent years.
Take alcohol.  Despite the idea that licensing laws have been liberalised in the UK, 
there’s an underlying philosophy with considerable traction that emphasises that 
alcohol is harmful in itself – and population measures such as minimum unit 
pricing are genuinely being considered.  There’s also designated public place 
orders and Reducing the Strength' campaigns that restrict where and when 
people can drink alcohol, and even what can be sold.
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On tobacco, advertising restrictions have been imposed over the past few 
decades, and we’ve recently had standardised packaging introduced in Australia, 
and packs being kept behind closed doors in the UK.
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Restrictions on caffeine are being debated, and I’ve heard plenty of substance 
misuse professionals and youth workers worrying about energy drinks.
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At the same time, thinking about currently illegal substances, there’s a great deal 
of media coverage for the Global Commission on Drug Policy, which follows 
Transform’s ideal of heavily regulated legalised substance use.  And in practice, a 
number of US states (and other countries) have liberalised their policies on 
certain previously illegal substances – notably cannabis – that mean consumption 
and sometimes even retail is legal.  Transform’s model of legalised consumption 
isn’t so far away from where we currently are with tobacco in the UK: 
condemned and controlled, but legal.
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Throw into this mix the ‘disruptive innovations’ we’ll be hearing about later of e-
cigarettes and ‘legal highs’ and there’s an interesting mix where the old lines 
between licit and illicit substances aren’t so clear.
The planned approach of the Coalition to ‘legal highs’, where all psychoactive 
substances would be illegal by default except where they have already been 
legalised, highlights the inconsistency in allowing alcohol, tobacco and caffeine 
consumption, for example, and some people would hope this will open up a 
debate about why these differences exist.
But this sort of analysis is primarily based on big, largely national policy 
announcements.  I don’t think there’s anything wrong with this sort of approach 
– and it’s exactly how I approached my academic articles.  But, working in a local 
authority over the past few years, I’ve been acutely aware of how approaches 
can differ from one area to another, and how the big picture might vary when 
considered in detail.
The perspective and examples I’ll be giving today are only one element of policy 
– even only one element of what local areas have control over – but it should 
give you an idea of how there’s quite a variety of types of intervention on offer to 
policymakers, and these reflect different ideas of what is problematic about 
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substance use, which in turn reflect broader priorities and implications.  My focus 
on treatment is relevant when it’s one of the few directly allocated spending 
budgets in relation to psychoactive substances.
The starting point for this analysis is to consider the changes in funding and 
governance that have happened in relation to substance misuse treatment in the 
past few years.  If you look at my main job, as a commissioner of substance misuse 
treatment services, for a decade or so before 2013, local areas used to be given 
funding for drug treatment by a specialist agency of the Department of Health: 
the National Treatment Agency (NTA).
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As an aside at this point, I should note that if you're interested in the longer and 
broader history of drug treatment in the UK, as well as Virginia Berridge, Alex 
Mold has written some excellent engaging articles.
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Now, apologies to those of you for whom this is stating the obvious, but I’ll just 
sketch things relatively quickly.  [SLIDE]  The NTA was very much a New Labour 
creation, and focused on a specific group of drug users, whether referred to as 
PDUs (problem drug users), OCUs (opiate or crack users) or more recently simply 
opiate users – that is, heroin.  The NTA determined what funding each local 
authority area would receive for drug treatment, and set out prescriptive 
requirements for local areas in terms of how they had to plan and arrange their 
treatment systems.  The key approach was methadone maintenance treatment, 
which had the logic of stopping someone injecting street heroin in favour of 
drinking a different, prescribed opioid.  The rationale is that by reducing injecting 
the risk of blood-borne virus transmission is cut, and you also remove the need 
for that person to steal to fund their (physical) dependency because you’re giving 
them the methadone free.
The funding for this was channelled through Drug and Alcohol Action Teams 
(DAATs), which were intended to be local partnerships of all interested 
organisations: local authorities, PCTs, Police, Probation, Prisons and so on.  And 
crucially, in fact, much of the funding that ended up going towards drug 
treatment had originated from a patchwork of sources from all these 
organisations.
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Regardless of the many potential justifications for funding drug treatment, the 
public rationale unfailingly focused on criminal justice issues.  Drug treatment 
was a way of being ‘tough on the causes of crime’.  Benefits in terms of reducing 
the prevalence of HIV or Hepatitis C were mentioned, but to give just one 
example, when the NTA released a Value for Money calculator, the detail – and 
the biggest ‘savings’ to the public purse – related to crimes that would be 
avoided if a drug user were engaged in methadone maintenance treatment.
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Paul Hayes, the former Chief Exec of the NTA has continued to make this 
argument since the demise of the organisation, most recently in a Guardian 
article just a couple of weeks ago. 
This model of treatment is based on providing intensive, focused support for a 
relatively small group within society.  The NTA provided estimates of the number 
of heroin and crack users in each local area, and commissioners had to show 
what proportion of this specific group they were engaging in treatment.  Funding 
was to a large extent determined by how many of these people accessed drug 
treatment.
In the new commissioning world, two things have become standard orthodoxies:
First, alcohol has been the ‘poor relation’ in terms of treatment, because the NTA 
never explicitly granted funding for it; and
Second, the old model focused on getting people into treatment rather than 
moving them through to ‘recovery’, however that is defined.
I’ll spend more time today on the first of these claims.
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The apparent rebalancing of treatment towards alcohol is about more than 
making sure that services are open to alcohol users as well as heroin users – in 
Dorset, for example, because of the nature of the area, we’ve already got a much 
higher proportion of alcohol users in our system than most other areas.  The shift 
is emblematic of the change in governance, from the NTA to PHE (there’s always 
got to be an impenetrable abbreviation) – that is, Public Health England.
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And here’s the shift, signalled in the name: ‘treatment’ to ‘public health’.  The 
approach of public health is to think in terms of small shifts across a whole 
population: if we all reduce our alcohol consumption by a unit or two a week, 
we’d reduce the total numbers of alcohol-related deaths by a big number at an 
aggregate level, though the change in our individual risk would be barely 
noticeable.  Alcohol Brief Interventions are the big tool available to local 
commissioners on this agenda, hence the title of my presentation.  The old 
model of intensive treatment for heroin users doesn’t fit this new philosophy –
and note that alcohol is one of PHE’s identified priorities, whereas drugs are not.
People at DrugScope like Marcus Roberts and Andrew Brown have written and 
spoken about this point, so I don’t want to labour it here.
Another crucial change in the funding approach is that money is no longer ring-
fenced for drug treatment (and soon won’t even be ringfenced for public health 
activities more broadly) – and it’s not based on performance metrics relating to 
heroin users.
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Perhaps just as importantly, this is no longer (even if only in principle) a 
patchwork of funding tied up through partnership arrangements; it’s been 
wrapped up into the general local authority grant from central government 
(though as I say for the moment it remains ringfenced for public health).  You can 
see how important this debate about the nature of substance use is when you 
look at how much of the public health budget is currently consumed by drug and 
alcohol treatment services. 
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How much would public health want to get their hands on that for streams of 
work they feel have been underfunded historically?  And how much would local 
authorities want to siphon that off to fund the forthcoming crisis in adult social 
care, illustrated by Barnet’s ‘graph of doom’?
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A recent press release from the Local Government Association actually stated this 
explicitly.
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From PHE, we see the move away from that kind of exceptionalism afforded 
heroin (and crack) use in the past.  Guidance for alcohol, illicit drugs and tobacco 
are now all lumped together by PHE, in another example of that convergence I 
was talking about earlier.
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But the change is more than this.  The changes relating to funding are part of a 
broader shift to local autonomy.  At a UK level, lots of elements of alcohol policy 
at least are devolved, and you’d find a different approach to drug treatment in 
Scotland.  This is also played out at local level – and here’s where some of my 
personal experience comes in.  PHE guidance just doesn’t carry the same weight 
as NTA requirements.  That’s actually the aim of the government’s localism 
approach, and has lots of strengths: Dorset no longer needs to produce a crack 
strategy when there’s hardly any crack use in the county, and it can develop a 
different approach to legal highs from Kent, where the supply operates much 
more through ‘head shops’ than in Dorset. On that issue of legal highs and local 
trends I can highly recommend this recent article in Mixmag by Mike Power 
called Small Towns, Crap Drugs.
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But, as any political scientist worth their salt would point out, policymaking isn’t 
a neutral, objective process of fitting a tailored solution to a specific problem 
identified through detailed evidence.  This autonomy means that decisions are 
shaped by local views, sensibilities and beliefs.  It’s also important to note that, 
as in that Kent example, the regulation of psychoactive substances comes under 
the remit of Trading Standards as much as the Police, for example; there are a lot 
of perspectives and agencies involved with this agenda.
If this presentation has any key message, it’s not really to identify detailed 
patterns in substance misuse governance and priorities at a local level; it’s more 
to note that we can’t yet tell how this is playing out.  So I want to stress how 
important it is that future research doesn't only take the approach of my 
academic work – which some might describe as a little lazy – of reading policy 
documents and government announcements. We need research that looks at 
how drug and alcohol policy plays out locally.
I'm not saying we should only take a micro-level approach: if you read about 
small towns, crap drugs, it’s clear the situation is the result of local dynamics 
mixed with national policy and international treaties and trade.  But – though I'd 
be happy to be persuaded otherwise – I think there's an opportunity to do more 
policy-oriented local research.  Where research in the field does look at micro 
areas in the UK, in my experience it's less about policy-making and more about 
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analysis of situations – for example, how well are individual treatment or A&E 
services dealing with substance use issues, or what does the night-time economy 
look like.
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To give another example of the sort of thing I have in mind, [SLIDE] let’s consider 
Nalmefene.  This is a drug to reduce alcohol consumption by people who are 
drinking more than guidelines, but without being physically dependent.
There's important high-level national and international context for this.  The drug 
has been developed by pharmaceutical company Lundbeck, which sponsors 
Alcohol Concern (note that both have an interest in problematising what some 
might see as relatively low levels of alcohol consumption) and it may not be a 
coincidence that the development of this use for an opiate derivative comes at a 
time when the treatment agenda has been moving away from prescribing for 
opiate addiction towards greater psychological input, and more focus on alcohol 
treatment even for those at the lower levels of the consumption spectrum.
But what does all that actually mean for drinkers themselves?  Well, that will 
depend on what arrangements are made by local commissioners – and they have 
considerable influence over how these sorts of developments pan out.  And I’m 
not just interested in whether (or how) Nalmefene is prescribed, but why that 
situation has come about.
And this isn't just dependent on views of substances, but also broader ideas of 
budgets and responsibilities.  A question like "can crime and community safety 
be seen as a public health responsibility?" is crucial in this respect, and might be 
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answered very differently in different parts of the country.  A case could be made 
that illicit use and crime damage population health as much as by affecting 
people's use of public space and eroding social capital within a community, as by 
transmitting of Hep C.  That's an argument that will be played out in town and 
county halls across the country; not Westminster.
But I’m here not only as a researcher but as something of a practitioner, and 
although this may not be the right setting, I'd like to finish with some practical or 
political reflections on the implications of the apparent convergence of attitudes 
on different psychoactive substances – and maybe this amounts to a local policy 
position of mine that another researcher should be analysing.
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My concern is not in identifying convergence as much as recommending it – as 
Transform do.  For all its intellectual coherence and consistency, this position 
poses issues for setting strategic priorities.  Not all drugs carry the same risks, for 
a variety of reasons.  An argument of exceptionalism drove the investment into 
heroin treatment.  This approach had its downsides (potentially stigmatising and 
singling out heroin users as unusual and pathologically criminal) but it did 
provide a framework that meant support was focused on some of the most 
vulnerable people in society – those who have the least ‘recovery capital’ to use 
the currently fashionable phrase.  This might be seen as fitting with the public 
health idea of ‘proportionate universalism’, but this is a very difficult concept to 
understand and convey, and remains focused on the directly health-related 
outcomes relating to substance use.  If policy is to be effective, we can’t simply 
understand substance use through a public health lens.
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And this is where I’m going to finish – with a slightly uncomfortable echo of 
Owen Paterson’s claim on Question Time the other week: drug use isn’t the same 
for everyone.
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But I’d like to attempt to cover this point with the veil of academic legitimacy by 
noting how use does vary by our understandings of drug, set, and setting – and 
that goes for policymakers and those involved with service provision as much as 
users themselves.  Let’s remember to keep thinking about the detail and range of 
perspectives in this field, and local variations, and how those might shape policy 
in the future.
Thank you. 
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